1. Home
  2. STTK vs MATW Comparison

STTK vs MATW Comparison

Compare STTK & MATW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$5.65

Market Cap

652.4M

Sector

Health Care

ML Signal

HOLD

Logo Matthews International Corporation

MATW

Matthews International Corporation

HOLD

Current Price

$19.25

Market Cap

639.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
MATW
Founded
2016
1850
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
652.4M
639.2M
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
STTK
MATW
Price
$5.65
$19.25
Analyst Decision
Strong Buy
Buy
Analyst Count
12
3
Target Price
$15.40
★ $31.33
AVG Volume (30 Days)
★ 1.2M
670.8K
Earning Date
11-09-2026
11-19-2026
Dividend Yield
N/A
★ 5.36%
EPS Growth
53.02
★ 59.07
EPS
N/A
★ N/A
Revenue
$1,000,000.00
★ $1,795,737,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.72
$18.42
52 Week High
$8.33
$30.93

Technical Indicators

Market Signals
Indicator
STTK
MATW
Relative Strength Index (RSI) 44.67 47.58
Support Level $5.19 $18.48
Resistance Level $6.00 $19.72
Average True Range (ATR) 0.36 0.44
MACD 0.04 0.10
Stochastic Oscillator 43.49 71.98

Price Performance

Historical Comparison
STTK
MATW

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About MATW Matthews International Corporation

Matthews International Corp is a provider of memorialization products, industrial technologies and brand solutions. The company's segments are Memorialization, Industrial Technologies and Brand Solutions. The memorialization offerings include bronze and granite memorials, caskets, and cremation-related products and equipment for cemeteries and funeral homes. Its Industrial Technologies segment designs, manufactures, services, and sells custom energy storage systems and product identification and warehouse automation solutions. The Brand Solutions segment provides brand management, pre-media, printing plates and cylinders, imaging, digital asset management, merchandising displays, and marketing and design services. The majority of revenue is generated by Memorialization.

Share on Social Networks: